Complex immuno-gene medical composition for inhibiting tumor cells
US7323450B2 · kind B2 · utility
5Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2004 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Jun 2, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/5443
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a complex immuno-gene medical composition for activating NK cells to enhance a host immune system. The composition includes a plurality of cytokines, including Th1 and Th2 cytokines. Th2 cytokines antagonize TGF-β inhibiting NK cells to disable the inhibition of the immune system. Th1 cytokines activate NK cells in a host to enhance the host's ability to fight against tumor cells. By use of the complex immuno-gene medical composition, removal of tumor cells is expected.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.